Medical specialists from Cameroon tagged as investigators in clinical trials studying Onchocerciasis, Ocular

Total 1 results

Joseph Kamgno, MD
Seen in:
- Yaoundé, Centre de recherche sur les filarioses et autres maladies tropicales (CRFilMT)
Trials:
- NCT04049851 (Principal Investigator)
- NCT04035174 (Principal Investigator)
Conditions:

Clinical Trials on Onchocerciasis, Ocular

Programme National de Lutte contre l'Onchocercose...

Completed

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients (EOLoa)

Onchocerciasis, Ocular | Loiasis

Congo
Center for Research on Filariasis and Other Tropical...

Active, not recruiting

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients (EOLoa)

Onchocerciasis, Ocular | Loiasis

Cameroon
Bayer

Recruiting

A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants

Soil-transmitted Helminth Infection | Onchocerciasis (River Blindness)

Germany
Washington University School of Medicine
National Public Health Institute of Liberia

Enrolling by invitation

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

Onchocerciasis | Onchocerciasis, Ocular | Tropical Disease | Onchocercal Subcutaneous Nodule | Onchocerca Infection

Liberia
Laboratorios Sophia S.A de C.V.

Completed

Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+ (PRO-172)

Tolerability | Safety | Ocular Surface | Ocular Comfort

Mexico
Shiraz University of Medical Sciences

Completed

The Effect of Intravenous Magnesium Sulfate on Intraocular Pressure Following Tracheal Intubation

Increased Intra Ocular Pressure (IOP)

Iran, Islamic Republic of
National Taiwan University Hospital

Unknown

Comparison of Different Drugs on Ocular Surface Disease in Glaucoma Patients: a Prospective Randomised Study

Glaucoma; Ocular Disorders (I.E. Caused by Ocular Disorders)

Taiwan
CHA University
Hanlim Pharm. Co., Ltd.

Unknown

Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial

Glaucoma | Ocular Hypertensive

Korea, Republic of
Western Galilee Hospital-Nahariya

Unknown

The Effect of Two Different Artificial Respiration Methods on the Intraocular Pressure During Surgery Under General Anesthesia

Intra Ocular Hypertension
Johnson & Johnson Vision Care, Inc.

Completed

Characterizing the Intraocular Scattering at Different Wavelengths

Vision, Ocular

United States

Subscribe